Pfizer’s New mRNA Flu Vaccine Shows Promise Amid Approval Concerns
Pfizer’s new mRNA-based flu vaccine has demonstrated superior efficacy compared to traditional flu shots, according to a recent Phase III trial published in the New England Journal of Medicine. The…